Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Allena Pharmaceuticals Inc.
DescriptionOral recombinant oxalate degrading enzyme
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard IndicationHyperoxaluria
Indication DetailsTreat hyperoxaluria; Treat hyperoxaluria and kidney stones; Treat secondary hyperoxaluria; Treat secondary hyperoxaluria and recurrent kidney stones
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today